Home | Welcome to Contract Pharma   
Last Updated Wednesday, May 22 2013
Print

Industry News

Related Searches:

Filter by:

Roche Bids To Buy Up Genentech
July 21, 2008
Roche has proposed to acquire the outstanding interest in Genentech for a total of approximately $43.7 billion. Roche acquired a majority in Genentech in 1990 and currently owns 55.9% of the company.     Under the plan, Genentech wi…   Read More »
AMRI Expands Singapore Lab
July 21, 2008
AMRI opened its first in vitro biology lab in Singapore and completed a 10,000-sq.- ft. lab expansion for medicinal chemistry discovery services, doubling the capacity of its Science Park III facility.     The in vitro biology group…   Read More »
Teva To Acquire Barr Pharma
July 18, 2008
Teva Pharmaceutical Industries and Barr Pharmaceuticals have signed a definitive agreement under which Teva will acquire Barr for $7.5 billion plus the assumption of approximately $1.5 billion of debt. The acquisition will expand Israel-based Teva's…   Read More »
Synomics Successfully Completes FDA Audit
July 18, 2008
The FDA has completed an inspection of Synomics Pharmaceutical Services' facilities and operations in Wareham, MA. The inspection included both PAI and general regulatory compliance, as Synomics Pharma had been named in three NDAs. No 483's were issu…   Read More »
HollisterStier Gets MHRA And FDA Certifications For New Filling Line
July 17, 2008
HollisterStier Contract Manufacturing received its certificate of GMP compliance by the Medicines and Healthcare Products Regulatory Agency (MHRA). This certification was issued following an inspection of the company's facilities, quality systems and…   Read More »
3M Designs New Systemic Delivery System
July 16, 2008
3M Drug Delivery Systems has designed a proof-of-concept device using a solid microstructured transdermal system (sMTS) for the systemic delivery of high potency pharmaceuticals. The technology was showcased this week at the annual meeting of the Con…   Read More »
Roche To Suspend HIV Research
July 14, 2008
Roche plans to suspend its HIV research because pending medicines fail to show significant improvement over existing therapies, according to a company statement. The company also claimed it will "refocus resources within virology on diseases in…   Read More »
Merck, Lilly, Pfizer Establish Enlight JV.
July 10, 2008
Merck, Lilly, and Pfizer have joined forces to create new drug discovery and development methods aimed at saving time and money by reducing the failure rate of clinical trials. The three companies and PureTech Ventures LLC have invested $39 million t…   Read More »
Novartis To Buy Out Speedel Shares
July 10, 2008
Novartis AG plans to acquire the remaining shares of Speedel Holding AG for approximately $881 million, according to a company statement. Novartis currently holds 61.4% of the company. The acquisition would give Novartis full control over the promisi…   Read More »
Lilly To Acquire SGX Pharmaceuticals
July 9, 2008
Lilly has signed a definitive merger agreement to acquire SGX Pharmaceuticals, Inc. for approximately $64 million in cash. SGX, based in San Diego, CA, is a biotechnology company focused on oncology drug discovery and development.    …   Read More »
Akorn Enters Exclusive Manufacturing Pact
July 9, 2008
Akorn, Inc. has entered into a 10-year exclusive contract manufacturing supply agreement with an undisclosed pharmaceutical firm. Under the terms of the agreement, Akorn will be responsible for the manufacturing and supply of several injectable drug…   Read More »
AAIPharma Gains EU GMP Certification
July 9, 2008
AAIPharma received certification from Sweden’s Medical Products Agency (MPA) for EU Good Manufacturing Practice (GMP) compliance of its Wilmington, NC operations. The company's tablet, capsule and other solid dose drug manufacturing and testing…   Read More »
No-Go For Pfizer Plant Sale In Cork
July 8, 2008
The pending sale of Pfizer's Little Island and Loughbeg plants in Cork, Ireland did not go through, according to a company statement, leaving 480 jobs at risk. The potential buyer withdrew its offer, citing that the facility does not meet its require…   Read More »
Fresenius To Acquire APP Pharma
July 7, 2008
Fresenius SE has agreed to acquire APP Pharmaceuticals, a provider of hospital-based injectable pharmaceutical products for $3.7 billion. The agreement also includes a contingent value right ("CVR") that could deliver as much as $970 millio…   Read More »
F.I.S. President Ferrari Dies
July 4, 2008
Gianfranco Ferrari, chairman and president of Fabbrica Italiana Sintetici S.p.A. (FIS) died on on March 9 at the age of 84. With his father and two brothers, Mr. Ferrari founded what has become the largest cGMP manufacturer in Italy in 1957 and creat…   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: